AU2002228652A1 - Treatment of disorders using polyethylenimine diazeniumdiolate - Google Patents

Treatment of disorders using polyethylenimine diazeniumdiolate

Info

Publication number
AU2002228652A1
AU2002228652A1 AU2002228652A AU2865202A AU2002228652A1 AU 2002228652 A1 AU2002228652 A1 AU 2002228652A1 AU 2002228652 A AU2002228652 A AU 2002228652A AU 2865202 A AU2865202 A AU 2865202A AU 2002228652 A1 AU2002228652 A1 AU 2002228652A1
Authority
AU
Australia
Prior art keywords
disorders
treatment
polyethylenimine diazeniumdiolate
diazeniumdiolate
polyethylenimine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002228652A
Inventor
Daniel Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Akron
Original Assignee
University of Akron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Akron filed Critical University of Akron
Publication of AU2002228652A1 publication Critical patent/AU2002228652A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002228652A 2000-11-27 2001-11-26 Treatment of disorders using polyethylenimine diazeniumdiolate Abandoned AU2002228652A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72294500A 2000-11-27 2000-11-27
US09722945 2000-11-27
PCT/US2001/044212 WO2002041902A1 (en) 2000-11-27 2001-11-26 Treatment of disorders using polyethylenimine diazeniumdiolate

Publications (1)

Publication Number Publication Date
AU2002228652A1 true AU2002228652A1 (en) 2002-06-03

Family

ID=24904099

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002228652A Abandoned AU2002228652A1 (en) 2000-11-27 2001-11-26 Treatment of disorders using polyethylenimine diazeniumdiolate

Country Status (2)

Country Link
AU (1) AU2002228652A1 (en)
WO (1) WO2002041902A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718603A4 (en) 2004-02-09 2009-09-23 Noxilizer Inc Nitric oxide-releasing molecules
ES2326387T3 (en) * 2005-03-24 2009-10-08 Nolabs Ab COSMETIC TREATMENT WITH NITRIC OXIDE, DEVICE FOR CARRYING OUT SUCH TREATMENT AND MANUFACTURING PROCEDURE OF THE SAME.
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
WO2016022170A1 (en) 2014-08-08 2016-02-11 Novan, Inc. Topical emulsions
JP6513667B2 (en) 2013-08-08 2019-05-15 ノヴァン，インコーポレイテッド Topical composition and method of using the same
CN103965469B (en) * 2014-04-25 2016-09-07 南京大学 Liquid exogenous NO donor and methods for making and using same thereof
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
KR102495101B1 (en) 2014-07-11 2023-02-02 노반, 인크. Topical antiviral compositions and methods of using the same
US10912743B2 (en) 2016-03-02 2021-02-09 Novan, Inc. Compositions for treating inflammation and methods of treating the same
US11166980B2 (en) 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
CA2705474C (en) * 1996-09-27 2013-07-16 The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates
WO2001092215A2 (en) * 2000-06-02 2001-12-06 Us Health Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same

Also Published As

Publication number Publication date
WO2002041902A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
AU2002257936A1 (en) Methods of well treatment
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2001265253A1 (en) Treatment of hiv using hyperthermia
IL151833A0 (en) Improved treatment of neovascularization
HK1048069A1 (en) Treatment of neurotic disorders.
AU2002231206A1 (en) Treatment of depression
AUPR074500A0 (en) Treatment of t cell disorders
AU2002360555A1 (en) Treatment of genitourinary tract disorders
AU2002228652A1 (en) Treatment of disorders using polyethylenimine diazeniumdiolate
AU2001239510A1 (en) Treatment of renal disorders
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
AU2002365936A1 (en) Compositions and methods to treat gastrointestinal disorders
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU3899100A (en) Treatment of hyperactivity disorders
AU2080201A (en) Treatment of addiction disorders
AU2001253560A1 (en) Methods of treatment
AU3582101A (en) The treatment of functional gastrointestinal disorders
AU2001272649A1 (en) Treatment of movement disorders
HUP0301798A3 (en) Treatment of eating disorders using carboxyalkylethers
GB0021060D0 (en) Treatment of functional gastrointestinal disorders
AU2002218335A1 (en) Combination therapy for treatment of serotonergic disorders
AUPR082000A0 (en) Treatment of bone disorder
AU2002241216A1 (en) Zinc-sensing receptor and methods of treatment of disorders associated herewith